SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
SCHOTT Pharma AG & Co KgaA
Revenue
SCHOTT Pharma AG & Co KgaA
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Revenue
€898.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
E
|
Evotec SE
XETRA:EVT
|
Revenue
€781.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
25%
|
Gerresheimer AG
XETRA:GXI
|
Revenue
€2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
See Also
What is SCHOTT Pharma AG & Co KgaA's Revenue?
Revenue
898.6m
EUR
Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Revenue amounts to 898.6m EUR.
What is SCHOTT Pharma AG & Co KgaA's Revenue growth rate?
Revenue CAGR 3Y
15%
Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for SCHOTT Pharma AG & Co KgaA have been 15% over the past three years .